Linda Rubenstein, who takes a Genzyme drug to treat Gaucher disease, said she would not have been able to have her son, Zach, (left) without the medication.
(Josh Reynolds for The Boston Globe)
Genzyme plight leaves patients uneasy
Linda Rubenstein, who takes a Genzyme drug to treat Gaucher disease, said she would not have been able to have her son, Zach, (left) without the medication.
(Josh Reynolds for The Boston Globe)
Ten-month-old Hannah Ostrea’s life hinges on an expensive drug made by just one company, Genzyme Corp. , based in Cambridge. (Full article: 1145 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
